Showing results (651-660 of 9,056) with videos related to

Sort By:
Pageof 906
Rheumatology (Oxford, England)|February 5, 2017
Radiographic sacroiliitis develops predictably over time in a cohort of familial spondyloarthritis followed longitudinallyFélicie Costantino, Nadine Zeboulon, Roula Said-Nahal, et al.
Rheumatology (Oxford, England)|February 5, 2017
The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease: a multicentre European Scleroderma Trials and Research group (EUSTAR) studyOtylia Kowal-Bielecka, Sylwia Chwiesko-Minarowska, Pawel L Bernatowicz, et al.
Rheumatology (Oxford, England)|February 7, 2017
Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexateShuntaro Saito, Yuko Kaneko, Kunihiro Yamaoka, et al.
Rheumatology (Oxford, England)|January 25, 2017
Delta neutrophil index contributes to the differential diagnosis between acute gout attack and cellulitis within 24 hours after hospitalizationJung Yoon Pyo, You-Jung Ha, Jason Jungsik Song, et al.
Rheumatology (Oxford, England)|August 2, 2003
Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxidative stressR M Nagler, F Salameh, A Z Reznick, et al.
Rheumatology (Oxford, England)|August 19, 2003
Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damageG S Alarcón, J M Roseman, G McGwin, et al.
Rheumatology (Oxford, England)|August 19, 2003
Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in KoreaK-T Oh, A H Anis, S-C Bae
Rheumatology (Oxford, England)|July 2, 2003
360-degree assessment in a multidisciplinary team settingT B Potter, R G Palmer
Rheumatology (Oxford, England)|October 3, 2003
Automated counting of white blood cells in synovial fluidR de Jonge, R Brouwer, M Smit, et al.
Rheumatology (Oxford, England)|February 26, 2004
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trialE L Matteson, C M Weyand, J W Fulbright, et al.
Pageof 906